Cell Financial Statements From 2010 to 2024
| CLCS Stock | USD 0.50 0.02 4.17% |
Check Cell Source financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cell Source's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cell financial statements analysis is a perfect complement when working with Cell Source Valuation or Volatility modules.
Cell |
Cell Source OTC Stock Shares Owned By Insiders Analysis
Cell Source's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Cell Source Shares Owned By Insiders | 32.13 % |
Most of Cell Source's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cell Source is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 32.13% of Cell Source are shares owned by insiders. This is 111.66% higher than that of the Healthcare sector and 126.59% higher than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Cell Source Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cell Source's current stock value. Our valuation model uses many indicators to compare Cell Source value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cell Source competition to find correlations between indicators driving Cell Source's intrinsic value. More Info.Cell Source is number one stock in return on asset category among its peers. It also is the top company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cell Source's earnings, one of the primary drivers of an investment's value.About Cell Source Financial Statements
Cell Source shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Cell Source investors may analyze each financial statement separately, they are all interrelated. The changes in Cell Source's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cell Source's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. Cell Source, Inc. was founded in 2012 and is headquartered in New York, New York. Cell Source operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cell OTC Stock Analysis
When running Cell Source's price analysis, check to measure Cell Source's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Source is operating at the current time. Most of Cell Source's value examination focuses on studying past and present price action to predict the probability of Cell Source's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Source's price. Additionally, you may evaluate how the addition of Cell Source to your portfolios can decrease your overall portfolio volatility.